BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  Anpac Bio Recognizes 30% Valuation Increase Upon Signing New Customers: 16th and 17th Global Fortune 500 Companies & International Insurance Provider

  Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company, announced the company’s valuation leapt nearly 30%

  July 25, 2018

   · 

  2 min read
• Business

  Genomma Lab Internacional Reports Second Quarter 2018 Results

  Genomma Lab Internacional, S.A.B. de C.V. announced its results for the second quarter ended June 30, 2018.

  July 25, 2018

   · 

  4 min read
• Drug Development

  BioArctic Announces Detailed Results of the BAN2401 Phase 2b Study in Early Alzheimer’s Disease Presented at AAIC 2018

  BioArctic AB announced on July 6 the positive topline results from the clinical Phase 2b study with BAN2401 in 856 patients with early Alzheimer’s disease.

  July 25, 2018

   · 

  14 min read
• Deals

  Gilead Sciences Announces Third Quarter 2018 Dividend

  Gilead Sciences, Inc. announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the third quarter of 2018.

  July 25, 2018

   · 

  1 min read